Financiación
Investigador/a: Maite Alvarez Rodriguez
9 financiaciones - 2.193.177€
2022
2021
-
ACTILNET. INTERLEUKIN-8 AND NEUTROPHIL EXTRACELULAR TRAPS AS ACTIONABLE HURDLES FOR CANCER IMMUNOTHERAPY
euro 498.850,00
-
Ensayo clínico fase I/II: nuevo enfoque terapéutico para el tratamiento de tumores sólidos con metástasis hepática
euro 270.482,00
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
euro 459.800,00
-
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
euro 126.500,00
-
CANCER ORGANOIDS COCULTURED WITH T CELLS AND FIBROBLASTS AS A NEW TOOL TO TEST AND
BENCHMARK IMMUNOTHERAPY STRATEGIES
euro 79.983,00
2020
-
Estudio traslacional EC MONEO
euro 151.000,00
-
MINCITH. Metabolic requirements for immune INfiltration in effective Cancer ImmunoTHerapy.
euro 124.768,00
2019
-
Synergy of antibodies exerting ADCC and Monalizumab
euro 108.471,00